COMMITTED

to improving the regulatory, investment,
and commercial environment for
antimicrobial drug development.

Learn More

BECOME A
MEMBER

Pharmaceutical and biotechnology companies
developing new antimicrobial therapeutics are
eligible for consideration of membership in AWG.

Learn More

Utilize the collective power of a coalition to improve the regulatory, investment and commercial environment for emerging antimicrobials companies.Learn More
Improve the regulatory, investment and commercial environment for emerging antimicrobials companies.Learn More
The AWG will work to advance the proposed policy changes to help improve the regulatory, political, and investment climate for developing new and innovative antimicrobials.Learn More

Member Companies